ARCHIVES

In Brief: What’s In A Name? DRCCA Doesn’t Do It; O’Conor Says ICRDB Program Should Consider New Challenges

This article is from The Cancer Letter archive.

Vol. 06 No. 39 | October 3, 1980

Download PDF Visit The Full Archive

Related Articles

FDA approves Irinotecan, Days After ODAC Meeting

June 21, 1996

Emory’s Winship Cancer Institute Wins NCI Cancer Center Designation

April 17, 2009

Von Eschenbach says oncology is undergoing a “revolutionary evolution.”

May 20, 2005

ASCO, FDA Website To Help Demystify Expanded Access

June 25, 2010

Risk Assessment Program Turns 30: Fox Chase Program Helps People Understand Genetic Risks for Cancer

October 25, 2021

NCI Promises Strong Monitoring Process Visco Calls For Independent Review; Rep. Dingell Plans Hearing April 13

April 1, 1994